Aistrup, Gary L <br/><br/>
Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation.  [electronic resource] 

 -  Cardiovascular research  Aug 2009 
 - 481-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1755-3245 
<br/><br/><label>Standard No.: </label>10.1093/cvr/cvp148  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials<br/>Animals<br/>Atrial Fibrillation--drug therapy<br/>Calcium Signaling--drug effects<br/>Carbachol--pharmacology<br/>Cardiovascular Agents--pharmacology<br/>Cats<br/>Cholinergic Agonists--pharmacology<br/>Cyclic AMP--metabolism<br/>Dogs<br/>GTP-Binding Protein alpha Subunits, Gi-Go--antagonists & inhibitors<br/>GTP-Binding Protein beta Subunits--metabolism<br/>GTP-Binding Protein gamma Subunits--metabolism<br/>Heart Atria--drug effects<br/>Microscopy, Confocal<br/>Myocytes, Cardiac--drug effects<br/>Parasympathectomy--methods<br/>Peptides--pharmacology<br/>Potassium--metabolism<br/>Receptor, Muscarinic M2--metabolism<br/>Refractory Period, Electrophysiological<br/>Time Factors<br/>Vagus Nerve--drug effects